Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

Glaxo Deal To Sell Ofatumumab Auto-Immune Indication Rights Completes

21st Dec 2015 11:42

Read More

GlaxoSmithKline's ViiV Venture To Buy Bristol-Myers HIV Assets

18th Dec 2015 07:14

Read More

GlaxoSmithKline Gets Positive Phase III Trial Results For Sirukumab

16th Dec 2015 14:06

Read More

BROKER RATINGS SUMMARY: Merrill Lynch Raises Glaxo To Buy From Neutral

9th Dec 2015 09:37

Read More

BROKER RATINGS SUMMARY: Nomura Cuts Kingfisher To Reduce From Neutral

7th Dec 2015 09:38

Read More

ReNeuron Group Appoints Ex-Glaxo Executive Owen To Board

4th Dec 2015 09:15

Read More

GlaxoSmithKline Gets European Marketing Authorisation For Nucala

3rd Dec 2015 06:20

Read More

GSK Says Nucala Available In US For Sub-group Of Patients With Severe Asthma

2nd Dec 2015 14:10

Read More

WINNERS & LOSERS SUMMARY: Greene King Stock In Good Spirits

2nd Dec 2015 10:31

Read More

BROKER RATINGS SUMMARY: JPMorgan, UBS And Barclays Like Ibstock

2nd Dec 2015 09:36

Read More

LONDON MARKET OPEN: Pharma Stocks Lead Gains; Sage Group Shares Down

2nd Dec 2015 08:29

Read More

GlaxoSmithKline Begins Dosing In Phase III Sirukumab Study

25th Nov 2015 11:30

Read More

GlaxoSmithKline Gets Expansion Approval For Volibris In Europe

24th Nov 2015 12:35

Read More

Circassia Pharmaceuticals Wins Approval For FLIXOTIDE pMDi Equivalent

24th Nov 2015 08:08

Read More

Vectura Loss Narrows On Better Royalty Income, Seebri Results Good

17th Nov 2015 08:45

Read More

BROKER RATINGS SUMMARY: JPMorgan And S&P Capital IQ Positive On ITV

11th Nov 2015 09:32

Read More

Dividends Calendar - Week Ahead

6th Nov 2015 16:21

Read More

US Regulator Approves Glaxo's Nucala To Treat Severe Asthma

5th Nov 2015 06:29

Read More

UPDATE: Glaxo Gets Good ViiV Results, Partners With Merck

3rd Nov 2015 13:02

Read More

Glaxo Gets Good ViiV Treatment Results, Outlines New Medicines

3rd Nov 2015 12:24

Read More

FTSE 100 Latest
Value10,436.29
Change71.50